A unique serotonin receptor in choroid plexus is linked to phosphatidylinositol turnover ( Communicated by Saul Roseman, January 23, 1986 ABSTRACT A novel serotonergic binding site, the 5-HTlc site, has been characterized recently in choroid plexus and several brain regions. The biochemical and physiological roles of this site have not been previously described. In this report we show that serotonin (5-hydroxytryptamine, 5-HT) stimulates phosphatidylinositol turnover in rat choroid plexus. The pharmacology of serotonin-stimulated phosphatidylinositol hydrolysis in choroid plexus was compared to the pharmacology in cerebral cortex, where this response is mediated by the serotonin 5-HT2 receptor. Serotonin increased phosphatidylinositol turnover in choroid plexus by 6-fold and in cerebral cortex by 2.5-fold. Serotonin was >10-fold more potent in choroid plexus (EC_% = 46 nM) than in cerebral cortex (EC50
= 540 nM). The serotonin antagonists ketanserin, mianserin, and spiperone inhibited the response in the two tissues with different potencies. In cerebral cortex all three exhibited nanomolar affinities consistent with their potencies at the 5-HT2 site. In choroid plexus, however, the rank order (mianserin > ketanserin >> spiperone) and absolute potencies were consistent with binding to the 5-HT1c site. These data suggest that the 5-HT1c site in choroid plexus is a functional receptor that utilizes phosphatidylinositol turnover as its biochemical effector system. The choroid plexus is the major site of cerebrospinal fluid (CSF) production, but the mechanisms controlling production and secretion of CSF are poorly understood (1) . Whereas the administration of either norepinephrine or serotonin decreases the secretion of CSF (2, 3) , serotonin is the most efficacious monoamine (3) . Since the choroid plexus and walls of the ventricles contain serotonergic fibers (4-7), it is possible that endogenous serotonin is involved in the regulation of CSF production. Therefore, it would be of considerable interest to find a receptor that mediates the effect of serotonin in the choroid plexus. We and others (8, 9) (10) .
Identification of a biochemical effector system that is linked to the 5-HT1c site would provide strong evidence that this site serves as a functional receptor in choroid plexus and other brain regions (8) . Recent data have shown that another serotonin receptor subtype is linked to phosphatidylinositol turnover in the mammalian brain. Based upon the finding that selective 5-HT2 antagonists inhibit serotonin-stimulated phosphatidylinositol turnover in cerebral cortex, we suggested that the response is mediated by the 5-HT2 binding site (11) . These findings have been confirmed and extended in brain (12) (13) (14) and other tissues (15) (16) (17) . Serotonin-stimulated phosphatidylinositol turnover in cerebral cortex is not secondary to release of another neurotransmitter or of arachidonic acid (18) , suggesting that the 5-HT2 receptor is directly coupled to phosphatidylinositol turnover. In the present studies, we have examined the effect of serotonin and serotonin antagonists upon phosphatidylinositol turnover in rat choroid plexus. The pharmacology of the response in choroid plexus was compared with that in cerebral cortex and with the pharmacology ofthe 5-HT1c and 5-HT2 binding sites.
The present data support the hypothesis that serotoninstimulated phosphatidylinositol turnover in choroid plexus is mediated by the 5-HTjc binding site in this tissue.
METHODS
Phosphatidylinositol Turnover. Phosphatidylinositol turnover in rat brain cerebral cortical slices was measured as described (12) (Fig. 1) . The effect of serotonin was much more robust in choroid plexus (5-to 6-fold stimulation) than in cerebral cortex (2.5-fold stimulation). Serotonin was also more potent in choroid plexus, with an EC50 of 46 nM as compared to an EC50 of 540 nM in cerebral cortex.
The putative serotonin antagonists ketanserin, mianserin, and spiperone inhibited the response to serotonin ( Fig. 2 (20) . Third, selective antagonists of other phosphatidylinositollinked receptors (Hl-histaminergic, a1-adrenergic, or muscarinic) did not inhibit the response to serotonin. Fourth, the 5-HT1c site is the only serotonin binding site that has been identified in choroid plexus. The 5-HT2, 5-HT1A, and 5-HTIB sites apparently are not present in this tissue (9, 10) .
Serotonin is by far the most potent neurotransmitter known to regulate a biochemical effector system in choroid plexus. Proc. Natl. Acad. Sci. USA 83 (1986) Apparent Ki values at phosphatidylinositol-linked receptors were estimated from the data in Fig. 2 . Apparent Ki values at the two binding sites were estimated from radioligand displacement data by the method of Cheng and Prusoff (19) . The binding data are presented as mean values ± SEM from three to five determinations. *Value obtained from Schild analysis of phosphatidylinositol turnover data in ref. 12. tValue obtained from competition binding data in ref. 12. tors linked to adenylate cyclase activation with an EC50 of 30 AM in this tissue (21) , which is lower by a factor of 650 than the potency of serotonin for the 5-HT1c-linked phosphatidylinositol turnover system. In addition, the potency of serotonin in the choroid plexus phosphatidylinositol system is approximately 10-fold higher than its potency in the 5-HT2-linked phosphatidylinositol turnover system in cerebral cortex. It is interesting to note that ketanserin has a relatively high affinity for both the 5-HT2 and 5-HT1c receptors. Because ketanserin binds with high affinity to the 5-HT2 site but not to the 5-HTlA and 5-HT1B sites, some investigators have interpreted the finding that a single concentration or dose of ketanserin blocks a response to serotonin as evidence that the response is mediated by the 5-HT2 binding site. However, caution should be taken in making such a conclusion because the 5-HT1c site is also blocked by ketanserin.
This study suggests that the 5-HT1c binding site on choroid plexus epithelial cells is a functional receptor linked to phosphatidylinositol turnover. This system may be involved in the known actions of serotonin on CSF production (3) . There are reports of indoleaminergic innervation of choroid plexus (5) and of low levels of serotonin in choroid plexus (22) ; however, the indoleaminergic innervation occurs mostly on the walls of blood vessels (5, 6) rather than on the epithelial cells, where the 5-HTlc site is localized (9) . It is possible that serotonin is released into CSF where it exerts a hormone-like action on choroid plexus. Rich presynaptic stores of serotonin are present in a dense network of serotonergic fibers present on the surface of ependymal cells lining the walls of the ventricles (4). These supraependymal fibers do not form recognizable synapses with ependymal cells (7) but may release serotonin into the CSF and activate 5-HT1c receptors in choroid plexus. There are many examples of such hormone-like action of serotonin in other systems (23) (24) (25) (26) .
Since the choroid plexus is a relatively simple tissue containing a monolayer of epithelial cells (27) , these cells can be readily dissociated and grown in culture (28) . This fact, coupled with the high serotonin 5-HTic receptor density and the robust phosphatidylinositol response in this tissue could make the choroid plexus a useful model system for studying the molecular mechanisms underlying the coupling of phosphatidylinositol-linked receptors to phospholipase C.
